Aromatase inhibitor-associated bone loss in breast cancer patients is distinct from postmenopausal osteoporosis (Q37256007)

From Wikidata
Jump to navigation Jump to search
scientific article published on 30 August 2008
edit
Language Label Description Also known as
English
Aromatase inhibitor-associated bone loss in breast cancer patients is distinct from postmenopausal osteoporosis
scientific article published on 30 August 2008

    Statements

    Aromatase inhibitor-associated bone loss in breast cancer patients is distinct from postmenopausal osteoporosis (English)
    30 August 2008

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit